Clin2
NCT06430528Possibly a fitRecruiting

Osilodrostat and steroid replacement for Cushing syndrome

Endogenous Cushing SyndromeAdrenal InsufficiencyHypercortisolism

Treatments studied

Part of Hormones & metabolism clinical trials.

This trial tests a new approach, called 'block-and-replace', for treating Cushing syndrome. You will take osilodrostat to lower high cortisol levels, along with a glucocorticoid (a steroid) to replace what your body needs. This study may help control the disease if surgery hasn't worked or isn't an option.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
12 people
Ages
18 years to 75 years
Study type
Observational

Who can take part

  • You have been diagnosed with Cushing syndrome caused by your body making too much cortisol (endogenous Cushing syndrome).
  • Your doctor is already considering osilodrostat as part of your treatment.
  • You have had surgery for Cushing syndrome that didn't fix it, or you are not able to have surgery.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06701838Not yet recruiting
Using osilodrostat and a special PET scan to find pituitary tumors in Cushing's disease

This study tests whether a combination of a drug called osilodrostat (which lowers cortisol levels) and a special PET scan can help find small pituitary tumors that MRI misses. This may help guide surgery or treatment for Cushing's disease.

NCT07703098Not yet recruiting· Phase 4
Comparing two steroids for adrenal insufficiency after long-term steroid use

This trial compares two steroid medicines (hydrocortisone and methylprednisolone) to see which one works better for people whose adrenal glands have stopped working properly after taking high doses of steroids for a long time. It aims to find the safest and most effective way to replace the missing hormones.

Ljubljana
NCT06980753Not yet recruiting
Wearable patch for continuous steroid monitoring in adrenal disorders

This study tests a wearable patch that measures cortisol and aldosterone levels continuously through skin fluid, aiming to improve management of adrenal disorders. If you have Addison's disease, Cushing syndrome, or primary aldosteronism, this could offer a more convenient way to monitor your condition.

São Paulo, São Paulo
NCT05193396Recruiting· Phase 4
Hydrocortisone trial for adrenal symptoms after stopping steroid pills

This trial tests whether hydrocortisone (a cortisol replacement) helps people who feel symptoms of adrenal insufficiency after they stop long-term prednisolone. It compares hydrocortisone versus placebo to see if symptoms improve and dosing is safer/effective.

Aarhus
NCT07247162Not yet recruiting· Phase 4
Osilodrostat for high blood pressure in Cushing's syndrome

This study tests a drug called osilodrostat (a pill) to see if it can lower blood pressure in people with Cushing's syndrome. If you have Cushing's and your blood pressure is still high despite medication, this trial might help you find better control.

NCT03708900Recruiting· Phase 2
Osilodrostat study for children with Cushing’s syndrome

This Phase 2 study tests how osilodrostat works in children and teens with Cushing’s syndrome—what the drug does in the body, how it affects hormones, and how safely it’s tolerated. It may help families who cannot have immediate surgery or whose surgery has already failed or is still pending.

San Francisco, California

Hear when a new Adrenal Insufficiency trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.